Trial · NCT02334215
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Predicted Probability Derived From the Generalized Linear Mixed Model of Opioid Urine Test Positive Results Over Time | 1, 3, 6, and 12 months post-release from incarceration | Predicted probability derived from the generalized linear mixed model opioid positive urine tests (0= negative; 1- positive) for heroin, oxycodone, methadone, or buprenorphine -- excluding the latter two positives when they results from prescribed medications to treat opioid use disorder) |
| Primary | Predicted Probability Derived From the General Linear Mixed Model of Entry Into Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form | 30 days post-release from incarceration | Predicted probability derived from the general linear mixed model of self-reported entry into treatment for opioid use disorder following release from incarceration and being in treatment 30 days post-release (0= no entry in treatment; 1= entry in treatment). |
| Secondary | Predicted Probability Derived From Generalized Linear Mixed Model of Meeting Opioid Use Disorder Criteria as Determined by the Modified Composite International Diagnostic Interview (CIDI) | one month period prior to the 3, 6, and 12 month post-release from incarceration | Predicted probability derived from the Generalized Linear Mixed Model of meeting the Data and Statistical Manual - 5 criteria for Opioid Use Disorder in response to modified CIDI interview (0= does not meet criteria; 1= meets criteria). |
| Secondary | Number of Participants With Arrests | one year post-release from incarceration | Official data on participant arrests subsequent to release from index incarceration. |
| Secondary | Drug Risk Score on the Risk Assessment Battery (RAB) | Baseline and 6, and 12 months post-release from incarceration | Drug Risk Scale Score on the Risk Assessment Battery. The scale's range goes from 0 to 22. Higher score represents greater frequency of drug risk behaviors |
| Secondary | Sex Risk Score on the Risk Assessment Battery (RAB) | Baseline and 6, and 12 months post-release from incarceration | Sex Risk Score on the Risk Assessment Battery (RAB). Higher scores represents greater risk. The score ranges from 0 to 18. |
| Secondary | Physical Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) | 1, 3, 6, and 12 months post-incarceration | The score on the Physical Domain Scale of the World Health Organization Quality of Life Scale-BREF (WHOQOL-BREF). The scales range is from 0 to 100. The higher score represents better quality of life. |
| Secondary | Psychological Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) | 1, 3, 6, and 12 months post-release from incarceration | Scale score on the Psychological Domain on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life. |
| Secondary | Social Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) | 1, 3, 6, and 12 month post-release from incarceration | Social domain scale score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. The higher score represents a better quality of life. |
| Secondary | Environmental Domain Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) | 1, 3, 6, and 12 months post-release from incarceration | Environmental domain score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) goes from 1 to 100. A higher score represents a better quality of life. |
| Secondary | Overall Quality of Life Score on the World Health Organization Quality of Life Scale (WHOQOL-BREF) | 1, 3, 6, and 12 month post-release from incarceration | Self report quality of life as reported by participants following release from their index incarceration on a scale from 1 to 5. A higher score is a better outcome. |
| Secondary | Predicted Probability Derived From the Generalized Linear Mixed Model of Being Retained in Treatment for Opioid Use Disorder on the Methadone Treatment Exposure Form | 12 months post-release from incarceration | Predicted Probability derived from the Generalized Linear Mixed of self-reported enrolled in treatment for Opioid Use Disorder at the time of the follow-up interview (0=not enrolled; 1=enrolled). |
| Secondary | Mean Number of Days of Criminal Activity in the Past 30 Days Reported by Participants on the Addiction Severity Index (ASI) | 1, 3, 6, and 12 months post-release from incarceration | Mean number of days reported by participants of their criminal activity during the 30 days preceding the Addiction Severity Index interviews |
| Secondary | Mean Number of Days of Illicit Opioid Use Reported by Participants in the Past 30 Days | 1, 3, 6, and 12 months post-release from incarceration | Mean number of participant self-reported days of heroin use in the 30 days preceding the interview on the Addiction Severity Index (ASI) |
| Secondary | Participant Self-reported Mean Number of Days of Cocaine Use in the Past 30 Days | 1, 3, 6, and 12 months post-release from incarceration | Participant self-reported mean number of days of cocaine use in the 30 days preceding the interview on the Addiction Severity Index (ASI) |
| Secondary | Predicted Probability Derived From the Generalized Linear Mixed Model of Meeting Cocaine Use Disorder Criteria in the Past 30 Days | 3, 6, and 12 months post-release from incarceration | Predicted Probability Derived from the Generalized Linear Mixed Model meeting Data and Statistical Manual - 5 criteria for Cocaine Use Disorder on the modified Composite International Diagnostic Interview (CIDI) (0=Does not meet criteria; 1=meets criteria). |
| Secondary | Days of Hospitalization (Health Care Utilization) on the Economic Form 90 (EF-90) | 12 months post-release from incarceration | Mean number of days hospitalized during the 12 months post-release from incarceration |
| Secondary | Cost of Substance Abuse Services | 12 months post-release from incarceration | Cost in US Dollars of substance abuse services on the modified Substance Abuse Services Cost Analysis Program |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02334215/registered